Home

Deformation date saw kras colon cancer Dust textbook scan

Targeting EGFR in metastatic colorectal cancer beyond the limitations of KRAS status: alternative biomarkers and therapeutic strategies | Biomarkers in Medicine
Targeting EGFR in metastatic colorectal cancer beyond the limitations of KRAS status: alternative biomarkers and therapeutic strategies | Biomarkers in Medicine

KRAS Positive Lung Cancer: Testing and Management
KRAS Positive Lung Cancer: Testing and Management

TAK1 Inhibition Promotes Apoptosis in KRAS-Dependent Colon Cancers - ScienceDirect
TAK1 Inhibition Promotes Apoptosis in KRAS-Dependent Colon Cancers - ScienceDirect

Cancers | Free Full-Text | Escaping KRAS: Gaining Autonomy and Resistance to KRAS Inhibition in KRAS Mutant Cancers
Cancers | Free Full-Text | Escaping KRAS: Gaining Autonomy and Resistance to KRAS Inhibition in KRAS Mutant Cancers

Microsatellite Instability and KRAS Mutation in Stage IV Colorectal Cancer: Prevalence, Geographic Discrepancies, and Outcomes From the National Cancer Database in: Journal of the National Comprehensive Cancer Network Volume 19 Issue 3 (2021)
Microsatellite Instability and KRAS Mutation in Stage IV Colorectal Cancer: Prevalence, Geographic Discrepancies, and Outcomes From the National Cancer Database in: Journal of the National Comprehensive Cancer Network Volume 19 Issue 3 (2021)

IJMS | Free Full-Text | Gene Therapy Targeting p53 and KRAS for Colorectal Cancer Treatment: A Myth or the Way Forward?
IJMS | Free Full-Text | Gene Therapy Targeting p53 and KRAS for Colorectal Cancer Treatment: A Myth or the Way Forward?

Gene mutation profiling in Chinese colorectal cancer patients and its association with clinicopathological characteristics and prognosis - Ye - 2020 - Cancer Medicine - Wiley Online Library
Gene mutation profiling in Chinese colorectal cancer patients and its association with clinicopathological characteristics and prognosis - Ye - 2020 - Cancer Medicine - Wiley Online Library

Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C | NEJM
Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C | NEJM

KRAS Biomarker | Colorectal Cancer Alliance
KRAS Biomarker | Colorectal Cancer Alliance

Predictive and prognostic biomarkers with therapeutic targets in advanced colorectal cancer
Predictive and prognostic biomarkers with therapeutic targets in advanced colorectal cancer

Prevalence of KRAS, NRAS and BRAF mutations in patients with colorectal... | Download Scientific Diagram
Prevalence of KRAS, NRAS and BRAF mutations in patients with colorectal... | Download Scientific Diagram

Full article: Discovery of a novel and a rare Kristen rat sarcoma viral oncogene homolog (KRAS) gene mutation in colorectal cancer patients
Full article: Discovery of a novel and a rare Kristen rat sarcoma viral oncogene homolog (KRAS) gene mutation in colorectal cancer patients

Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer | Molecular Cancer | Full Text
Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer | Molecular Cancer | Full Text

Differential Reprogramming of Isogenic Colorectal Cancer Cells by Distinct Activating KRAS Mutations | Journal of Proteome Research
Differential Reprogramming of Isogenic Colorectal Cancer Cells by Distinct Activating KRAS Mutations | Journal of Proteome Research

KRAS and extended RAS molecular profiling in metastatic colorectal cancer | Colorectal Cancer
KRAS and extended RAS molecular profiling in metastatic colorectal cancer | Colorectal Cancer

ADAM17-Dependent c-MET-STAT3 Signaling Mediates Resistance to MEK Inhibitors in KRAS Mutant Colorectal Cancer: Cell Reports
ADAM17-Dependent c-MET-STAT3 Signaling Mediates Resistance to MEK Inhibitors in KRAS Mutant Colorectal Cancer: Cell Reports

Personalized Cancer Treatment and the Myth of KRAS Wild-type Colon Tumors - Barbara L Parsons - Discovery Medicine
Personalized Cancer Treatment and the Myth of KRAS Wild-type Colon Tumors - Barbara L Parsons - Discovery Medicine

KRAS, NRAS and BRAF mutations in Greek and Romanian patients with colorectal cancer: a cohort study | BMJ Open
KRAS, NRAS and BRAF mutations in Greek and Romanian patients with colorectal cancer: a cohort study | BMJ Open

The Prognostic Impact of KRAS G12C Mutation in Patients with Metastatic Colorectal Cancer: A Multicenter Retrospective Observational Study - Chida - 2021 - The Oncologist - Wiley Online Library
The Prognostic Impact of KRAS G12C Mutation in Patients with Metastatic Colorectal Cancer: A Multicenter Retrospective Observational Study - Chida - 2021 - The Oncologist - Wiley Online Library

Frontiers | Molecular Network of Colorectal Cancer and Current Therapeutic Options
Frontiers | Molecular Network of Colorectal Cancer and Current Therapeutic Options

Progress towards individualized treatment of colorectal cancer UAB Barcelona
Progress towards individualized treatment of colorectal cancer UAB Barcelona

Clinical and prognostic features of patients with detailed RAS/BRAF-mutant colorectal cancer in Japan | BMC Cancer | Full Text
Clinical and prognostic features of patients with detailed RAS/BRAF-mutant colorectal cancer in Japan | BMC Cancer | Full Text

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis - The Lancet Oncology
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis - The Lancet Oncology

Mutations in APC, Kirsten-ras, and p53—alternative genetic pathways to colorectal cancer | PNAS
Mutations in APC, Kirsten-ras, and p53—alternative genetic pathways to colorectal cancer | PNAS